UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

Trials, 2022-06, Vol.23 (1), p.484-16, Article 484

2022

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial

BMJ open, 2021-09, Vol.11 (9), p.e047185-e047185

2021

Volltextzugriff (PDF)

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

PLOS global public health, 2022, Vol.2 (12), p.e0001337-e0001337

2022

Volltextzugriff (PDF)

Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?

Expert opinion on drug metabolism & toxicology, 2018-01, Vol.14 (1), p.59-82

2018

Volltextzugriff (PDF)

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

The New England journal of medicine, 2022-12, Vol.387 (25), p.2331-2343

2022

Volltextzugriff (PDF)

On tuberculosis and COVID-19 co-infection

The European respiratory journal, 2020-08, Vol.56 (2), p.2002328

2020

Volltextzugriff (PDF)

The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis

Clinical infectious diseases, 2024-03, Vol.78 (3), p.730-741

2024

Volltextzugriff (PDF)

Recent advances in the treatment of tuberculosis

Clinical microbiology and infection, 2024-09, Vol.30 (9), p.1107-1114

2024

Volltextzugriff (PDF)

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study

Antimicrobial agents and chemotherapy, 2022-06, Vol.66 (6), p.e0013622-e0013622

2022

Volltextzugriff (PDF)

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Volltextzugriff (PDF)

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?

International journal of antimicrobial agents, 2021-03, Vol.57 (3), p.106297, Article 106297

2021

Volltextzugriff (PDF)

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

The European respiratory journal, 2018-08, Vol.52 (2), p.1800537

2018

Volltextzugriff (PDF)

Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"

Antimicrobial agents and chemotherapy, 2020-03, Vol.64 (4)

2020

Volltextzugriff (PDF)

Early Low-Molecular-Weight Heparin Administration is Associated with Shorter Time to SARS-CoV-2 Swab Negativity

Antiviral therapy, 2020-01, Vol.25 (6), p.327-333

2020

Volltextzugriff (PDF)

Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges and future proposal

Infectious diseases (London, England), 2019-05, Vol.51 (5), p.392-394

2019

Volltextzugriff (PDF)

Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review

The New microbiologica, 2018-10, Vol.41 (4), p.282

2018

Volltextzugriff (PDF)

Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review

The New microbiologica, 2019-10, Vol.41 (4), p.282-290

2019

Volltextzugriff (PDF)

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

PLOS global public health, 2022-01, Vol.2 (12)

2022

Volltextzugriff (PDF)

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey

The New microbiologica, 2022-12, Vol.45 (4), p.260-268

2022

Volltextzugriff (PDF)

Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey

Le infezioni in medicina, 2022-09, Vol.30 (3), p.418-426

2022

Volltextzugriff (PDF)

Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross‐sectional study in rural B urundi

British journal of clinical pharmacology, 2015-05, Vol.79 (5), p.801-808

2015

Volltextzugriff (PDF)

Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting

Intensive care medicine, 2014-05, Vol.40 (5), p.759-760

2014

Volltextzugriff (PDF)

Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient

Le infezioni in medicina, 2016, Vol.24 (1), p.89-89

2016

Volltextzugriff (PDF)

Wound botulism after traumatic open fracture in Italy

Le infezioni in medicina, 2015-09, Vol.23 (3), p.280-282

2015

Volltextzugriff (PDF)

Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines

Le infezioni in medicina, 2014-06, Vol.22 (2), p.107-111

2014

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(122)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

On tuberculosis and COVID-19 co-infection

The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis

Recent advances in the treatment of tuberculosis

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"

Early Low-Molecular-Weight Heparin Administration is Associated with Shorter Time to SARS-CoV-2 Swab Negativity

Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges and future proposal

Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review

Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey

Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey

Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross‐sectional study in rural B urundi

Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting

Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient

Wound botulism after traumatic open fracture in Italy

Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines

Aktive Filter

Suchergebnisse filtern